176 related articles for article (PubMed ID: 37084069)
21. Successful treatment by azacitidine therapy of intestinal Behçet's disease associated with myelodysplastic syndrome.
Tanaka H; Shimizu N; Tougasaki E; Kawajiri C; Hashimoto S; Takeda Y; Sakai S; Takeuchi M; Ohwada C; Sakaida E; Takagi T; Nakaseko C
Int J Hematol; 2013 Apr; 97(4):520-4. PubMed ID: 23519573
[TBL] [Abstract][Full Text] [Related]
22. Secondary Pulmonary Alveolar Proteinosis Following Treatment with Azacitidine for Myelodysplastic Syndrome.
Hashimoto M; Itonaga H; Nannya Y; Taniguchi H; Fukuda Y; Furumoto T; Fujioka M; Kasai S; Taguchi M; Taniguchi H; Sato S; Sawayama Y; Atogami S; Iwasaki K; Hata T; Soda H; Moriuchi Y; Nakata K; Ogawa S; Miyazaki Y
Intern Med; 2020 Apr; 59(8):1081-1086. PubMed ID: 31875636
[TBL] [Abstract][Full Text] [Related]
23. Intestinal Behçet disease associated with myelodysplastic syndrome accompanying trisomy 8 successfully treated with abdominal surgery followed by hematopoietic stem cell transplantation: A case report.
Asano T; Sato S; Furuya MY; Takahashi H; Shichishima-Nakamura A; Ohkawara H; Fujiwara T; Gunji N; Hashimoto C; Momma T; Saito M; Nakano H; Watanabe G; Temmoku J; Fujita Y; Matsuoka N; Kobayashi H; Watanabe H; Mouri M; Mashiyama F; Sakuma H; Ohira H; Mori M; Ikezoe T; Migita K
Medicine (Baltimore); 2019 Nov; 98(46):e17979. PubMed ID: 31725663
[TBL] [Abstract][Full Text] [Related]
24. Successful Treatment of Behçet's Disease Associated with Acute Myeloid Leukemia with Myelodysplasia-related Changes Using Azacitidine and Tacrolimus before Allogeneic Hematopoietic Stem Cell Transplantation.
Nakamura Y; Matsuguma M; Tokunaga Y; Yamamoto K; Tanaka M; Tanaka Y; Yujiri T; Tanizawa Y
Intern Med; 2017; 56(10):1199-1202. PubMed ID: 28502936
[TBL] [Abstract][Full Text] [Related]
25. Allogeneic hematopoietic stem cell transplantation for juvenile myelomonocytic leukemia with intestinal Behçet's disease: A case report.
Liu C; Fu C; Guo X; Rong L; Li J; Fang Y
Int J Rheum Dis; 2024 Jan; 27(1):e14882. PubMed ID: 37771000
[TBL] [Abstract][Full Text] [Related]
26. Case report: Successful allogeneic stem cell transplantation in a child with novel GATA2 defect associated B-cell acute lymphoblastic leukemia.
Heropolitańska-Pliszka E; Piątosa B; Szmydki-Baran A; Kuczborska K; Miarka-Walczyk K; Pastorczak A; Młynarski W; Sędek Ł; Szczepański T; Ussowicz M
Front Immunol; 2022; 13():928529. PubMed ID: 35983050
[TBL] [Abstract][Full Text] [Related]
27. The spectrum of GATA2 deficiency syndrome.
Calvo KR; Hickstein DD
Blood; 2023 Mar; 141(13):1524-1532. PubMed ID: 36455197
[TBL] [Abstract][Full Text] [Related]
28. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.
Spinner MA; Sanchez LA; Hsu AP; Shaw PA; Zerbe CS; Calvo KR; Arthur DC; Gu W; Gould CM; Brewer CC; Cowen EW; Freeman AF; Olivier KN; Uzel G; Zelazny AM; Daub JR; Spalding CD; Claypool RJ; Giri NK; Alter BP; Mace EM; Orange JS; Cuellar-Rodriguez J; Hickstein DD; Holland SM
Blood; 2014 Feb; 123(6):809-21. PubMed ID: 24227816
[TBL] [Abstract][Full Text] [Related]
29. GATA2 deficiency in children and adults with severe pulmonary alveolar proteinosis and hematologic disorders.
Griese M; Zarbock R; Costabel U; Hildebrandt J; Theegarten D; Albert M; Thiel A; Schams A; Lange J; Krenke K; Wesselak T; Schön C; Kappler M; Blum H; Krebs S; Jung A; Kröner C; Klein C; Campo I; Luisetti M; Bonella F
BMC Pulm Med; 2015 Aug; 15():87. PubMed ID: 26264606
[TBL] [Abstract][Full Text] [Related]
30. Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome.
Falconi G; Fabiani E; Criscuolo M; Fianchi L; Finelli C; Cerqui E; Pelosi E; Screnci M; Gurnari C; Zangrilli I; Postorino M; Laurenti L; Piciocchi A; Testa U; Lo-Coco F; Voso MT
Leuk Res; 2019 Sep; 84():106191. PubMed ID: 31386932
[TBL] [Abstract][Full Text] [Related]
31. Successful allogeneic bone marrow transplantation for myelodysplastic syndrome complicated by severe pulmonary alveolar proteinosis.
Tabata S; Shimoji S; Murase K; Takiuchi Y; Inoue D; Kimura T; Nagai Y; Mori M; Togami K; Kurata M; Ito K; Hashimoto H; Matushita A; Nagai K; Takahashi T
Int J Hematol; 2009 Oct; 90(3):407-412. PubMed ID: 19693450
[TBL] [Abstract][Full Text] [Related]
32. Secondary pulmonary alveolar proteinosis complicating myelodysplastic syndrome results in worsening of prognosis: a retrospective cohort study in Japan.
Ishii H; Seymour JF; Tazawa R; Inoue Y; Uchida N; Nishida A; Kogure Y; Saraya T; Tomii K; Takada T; Itoh Y; Hojo M; Ichiwata T; Goto H; Nakata K
BMC Pulm Med; 2014 Mar; 14():37. PubMed ID: 24597668
[TBL] [Abstract][Full Text] [Related]
33. Donor-derived MDS/AML in families with germline
Galera P; Hsu AP; Wang W; Droll S; Chen R; Schwartz JR; Klco JM; Arai S; Maese L; Zerbe C; Parta MJ; Young NS; Holland SM; Hickstein DD; Calvo KR
Blood; 2018 Nov; 132(18):1994-1998. PubMed ID: 30232126
[No Abstract] [Full Text] [Related]
34. Germline GATA2 Mutation and Bone Marrow Failure.
McReynolds LJ; Calvo KR; Holland SM
Hematol Oncol Clin North Am; 2018 Aug; 32(4):713-728. PubMed ID: 30047422
[TBL] [Abstract][Full Text] [Related]
35. Allogeneic hematopoietic cell transplantation in patients with GATA2 deficiency-a case report and comprehensive review of the literature.
Simonis A; Fux M; Nair G; Mueller NJ; Haralambieva E; Pabst T; Pachlopnik Schmid J; Schmidt A; Schanz U; Manz MG; Müller AMS
Ann Hematol; 2018 Oct; 97(10):1961-1973. PubMed ID: 29947977
[TBL] [Abstract][Full Text] [Related]
36. Allogeneic stem cell transplantation without preconditioning in a child with therapy-related myelodysplastic syndrome: A case report.
Tung YL; Wang YL; Chang TY; Chiu CC; Wen YC; Jaing TH
Medicine (Baltimore); 2023 Feb; 102(6):e32770. PubMed ID: 36820588
[TBL] [Abstract][Full Text] [Related]
37. Heritable GATA2 mutations associated with familial AML-MDS: a case report and review of literature.
Gao J; Gentzler RD; Timms AE; Horwitz MS; Frankfurt O; Altman JK; Peterson LC
J Hematol Oncol; 2014 Apr; 7():36. PubMed ID: 24754962
[TBL] [Abstract][Full Text] [Related]
38. A novel germline GATA2 frameshift mutation with a premature stop codon in a family with congenital sensory hearing loss and myelodysplastic syndrome.
Nakazawa H; Yamaguchi T; Sakai H; Maruyama M; Kawakami T; Kawakami F; Nishina S; Ishikawa M; Kosho T; Ishida F
Int J Hematol; 2021 Aug; 114(2):286-291. PubMed ID: 33759087
[TBL] [Abstract][Full Text] [Related]
39. Correlation of somatic mutations with outcome after FLAMSA-busulfan sequential conditioning and allogeneic stem cell transplantation in patients with myelodysplastic syndromes.
Christopeit M; Badbaran A; Alawi M; Zabelina T; Zeck G; Wolschke C; Ayuk F; Kröger N
Eur J Haematol; 2016 Sep; 97(3):288-96. PubMed ID: 26680262
[TBL] [Abstract][Full Text] [Related]
40. rs1573858 GATA-2 homozygote variant associated with pulmonary alveolar proteinosis, cytopenia and neurologic dysfunction.
China N; Gurioli C; Maitan S; Poletti V
Pulmonology; 2020; 26(3):178-180. PubMed ID: 31672593
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
